Mayinglong Pharmaceutical Group Co Ltd (600993) — Financial Flexibility Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥152.93 Million (operating CF CN¥139.20 Million minus capex CN¥13.73 Million) represents 0% of total liabilities (CN¥909.82 Million). Check Mayinglong Pharmaceutical Group Co Ltd (600993) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mayinglong Pharmaceutical Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. See 600993 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Mayinglong Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 600993 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥719.82 Million | CN¥600.44 Million | CN¥921.49 Million | ▲ +9.2% |
| 2024 | 0.72x | CN¥701.46 Million | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.5% |
| 2023 | 0.89x | CN¥852.43 Million | CN¥604.07 Million | CN¥959.62 Million | ▲ +206.6% |
| 2022 | 0.29x | CN¥416.86 Million | CN¥341.85 Million | CN¥1.44 Billion | ▼ -64.4% |
| 2021 | 0.81x | CN¥662.27 Million | CN¥597.17 Million | CN¥812.72 Million | ▲ +128.3% |
| 2020 | 0.36x | CN¥328.40 Million | CN¥282.99 Million | CN¥919.89 Million | ▼ -56.8% |
| 2019 | 0.83x | CN¥537.94 Million | CN¥491.58 Million | CN¥650.49 Million | ▲ +42.6% |
| 2018 | 0.58x | CN¥333.21 Million | CN¥308.24 Million | CN¥574.67 Million | ▼ -29.7% |
| 2017 | 0.82x | CN¥398.08 Million | CN¥356.17 Million | CN¥482.99 Million | ▲ +29.7% |
| 2016 | 0.64x | CN¥304.84 Million | CN¥239.60 Million | CN¥479.88 Million | ▲ +8.4% |
| 2015 | 0.59x | CN¥306.78 Million | CN¥182.85 Million | CN¥523.31 Million | ▲ +30.6% |
| 2014 | 0.45x | CN¥218.54 Million | CN¥111.67 Million | CN¥486.89 Million | ▼ -3.1% |
| 2013 | 0.46x | CN¥213.62 Million | CN¥129.94 Million | CN¥461.22 Million | ▼ -6.1% |
| 2012 | 0.49x | CN¥202.01 Million | CN¥169.25 Million | CN¥409.56 Million | ▲ +38.7% |
| 2011 | 0.36x | CN¥120.06 Million | CN¥75.37 Million | CN¥337.70 Million | ▲ +416.9% |
| 2010 | 0.07x | CN¥22.13 Million | CN¥-11.42 Million | CN¥321.68 Million | ▼ -89.5% |
| 2009 | 0.65x | CN¥251.05 Million | CN¥216.11 Million | CN¥384.11 Million | ▲ +40.7% |
| 2008 | 0.46x | CN¥135.43 Million | CN¥102.59 Million | CN¥291.46 Million | ▲ +256.0% |
| 2007 | 0.13x | CN¥31.13 Million | CN¥6.49 Million | CN¥238.53 Million | ▼ -66.1% |
| 2006 | 0.39x | CN¥96.59 Million | CN¥75.27 Million | CN¥250.53 Million | ▼ -28.3% |
| 2005 | 0.54x | CN¥94.38 Million | CN¥58.43 Million | CN¥175.45 Million | ▼ -15.4% |
| 2004 | 0.64x | CN¥83.13 Million | CN¥54.19 Million | CN¥130.74 Million | ▲ +5.9% |
| 2003 | 0.60x | CN¥82.05 Million | CN¥67.52 Million | CN¥136.61 Million | — |